TZ Ref No.: TZ-8215C63
Czechia – Immunoglobulins – Immunoglubuliny SCIG VI. - HYQVIA
Doc ref no.
ted_europa_00746571-2026
Sector
Services
Contract Date
19 Oct 2026
Contract Value
CZK 6.7M
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Official Award Result
Status: Contract Awarded
Award Date: 19 Oct 2026
Awarded Contractor / Winner
Takeda Pharmaceuticals Czech Republic s.r.o.
Vídeňská 1958, Praha, 14000, Czech Republic
Awarded Contract Value:
CZK 6,723,750.00
Contract Description
The subject of the public contract is the regular supply of human immunoglobulin (HVLP Hyqvia) for subcutaneous application (SCIG) for the treatment of patients in approved indications according to the valid SPC on the date of submission of bids.
Related Procurement Opportunities
Similar tenders in Services